0
0

Helping Experts Accelerate Rare Treatments Act of 2022

12/29/2022, 11:48 PM

Congressional Summary of S 4071

Helping Experts Accelerate Rare Treatments Act of 2022

This bill modifies provisions relating to the approval of drugs for rare diseases and conditions, including by requiring regular reporting on the number and types of applications received and the extent to which external experts are consulted during the review process.

Current Status of Bill S 4071

Bill S 4071 is currently in the status of Bill Introduced since April 7, 2022. Bill S 4071 was introduced during Congress 117 and was introduced to the Senate on April 7, 2022.  Bill S 4071's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of April 7, 2022

Bipartisan Support of Bill S 4071

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
0
Republican Cosponsors
1
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 4071

Primary Policy Focus

Health

Alternate Title(s) of Bill S 4071

Helping Experts Accelerate Rare Treatments Act of 2022
Helping Experts Accelerate Rare Treatments Act of 2022
A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the treatment of rare diseases and conditions, and for other purposes.

Comments